Search results for "Azepine"
showing 10 items of 266 documents
CCDC 1973338: Experimental Crystal Structure Determination
2020
Related Article: Imre Pápai, Petri M. Pihko, Juha H. Siitonen, Dániel Csókás|2020|Synlett|31|1581|doi:10.1055/s-0040-1707201
CCDC 2131015: Experimental Crystal Structure Determination
2022
Related Article: Braulio M. Puerta Lombardi, Ethan R. Pezoulas, Roope A. Suvinen, Alexander Harrison, Zachary S. Dubrawski, Benjamin S. Gelfand, Heikki M. Tuononen, Roland Roesler|2022|Chem.Commun.|58|6482|doi:10.1039/D2CC01476A
CCDC 1915324: Experimental Crystal Structure Determination
2019
Related Article: U. Kolb, Y. Krysiak, S. Plana-Ruiz|2019|Acta Crystallogr.,Sect.B:Struct.Sci.,Cryst.Eng. and Mat.|75|463|doi:10.1107/S2052520619006711
CCDC 1453056: Experimental Crystal Structure Determination
2016
Related Article: Lei Wang, Sun Li, Marcus Blümel, Arne R. Philipps, Ai Wang, Rakesh Puttreddy, Kari Rissanen, Dieter Enders|2016|Angew.Chem.,Int.Ed.|55|11110|doi:10.1002/anie.201604819
CCDC 840881: Experimental Crystal Structure Determination
2012
Related Article: M.Cieslikiewicz, A.Bouet, S.Juge, M.Toffano, J.Bayardon, C.West, K.Lewinski, I.Gillaizeau|2012|Eur.J.Org.Chem.|2012|1101|doi:10.1002/ejoc.201101293
CCDC 840882: Experimental Crystal Structure Determination
2012
Related Article: M.Cieslikiewicz, A.Bouet, S.Juge, M.Toffano, J.Bayardon, C.West, K.Lewinski, I.Gillaizeau|2012|Eur.J.Org.Chem.|2012|1101|doi:10.1002/ejoc.201101293
Evaluation of carbamazepine uptake and metabolization by Typha spp., a plant with potential use in phytotreatment
2011
Abstract Phytoremediation technologies such as constructed wetlands have shown higher efficiencies in removal of pharmaceuticals from wastewaters than conventional wastewater treatment processes, and plants seem to have an important role in the removal of some of those compounds. In this context, a study was conducted to assess tolerance, uptake, and metabolism of the epilepsy drug, carbamazepine, by the macrophyte Typha spp. This evaluation was conducted in hydroponic solutions with 0.5–2.0 mg/L of this pharmaceutical for a maximum period of 21 days. The removal of carbamazepine from nutrient solutions by the plants reached values of 82% of the initial contents. Furthermore, a metabolite (…
Characterization of the binding of benzodiazepines to human serum albumin
1973
The binding of eleven benzodiazepine derivatives to human serum albumin (HSA) was determined by means of sephadex gel filtration. The albumin binding of the substances was characterized by the percentage of bound drug, the binding constants k +, K 1 and m, the number of binding sites per albumin molecule, and the free binding energy. Under the conditions chosen in these experiments there seems to exist only one binding site of the same type for all investigated benzodiazepines at the HSA molecule. The affinities of the benzodiazepines to this binding site are very different. It is discussed which part of the benzodiazepine molecule represents the main binding group.
Synthesis and Dopamine Receptor Selectivity of the Benzyltetrahydroisoquinoline, (R)-(+)-nor-Roefractine
1998
(R)-(+)-nor-Roefractine (1) was synthesized by the Bischler-Napieralski route, using asymmetric reduction of the 1, 2-didehydro precursor imine with sodium (S)-N-CBZ-prolinyloxyborohydride. Compound 1 was able to displace [3H]-raclopride (a D2 dopamine receptor-selective ligand) from its specific binding sites in rat striatum with selectivity vs [3H]-SCH23390 (D1 dopamine receptor-selective ligand).
Synthesis, benzodiazepine receptor binding and molecular modelling of isochromeno[4,3-c]pyrazol-5(1H)-one derivatives
2012
Abstract A series of isochromeno[4,3-c]pyrazole-5(1H)-one derivatives 7b–h were prepared and tested at 10 μM for their ability to displace specific [3H]flunitrazepam from bovine brain membranes. The substitution pattern of the above derivatives was shown to influence the receptor affinity. The most active compound of the series was 7e, showing a 54% inhibition of [3H]flunitrazepam binding. Compounds 7a–d,i were compared with the known isomers chromeno[4,3-c]pyrazole-4(1H)-ones 14a–d,i, showing that the isochromene/chromene isomerism influences the activity.